BPC Instruments AB offers instruments for measuring ultra-low gas volume and flow rate. Many biotechnological processes such as biogas production are performed by microorganisms. The company develops and sells automated analytical apparatuses that analyses these reactions.
2005
9
LTM Revenue $6.4M
LTM EBITDA n/a
$38.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BPC Instruments has a last 12-month revenue of $6.4M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, BPC Instruments achieved revenue of $5.2M and an EBITDA of $1.7M.
BPC Instruments expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See BPC Instruments valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $3.5M | $5.2M | XXX | XXX | XXX |
Gross Profit | $2.1M | $2.5M | XXX | XXX | XXX |
Gross Margin | 59% | 48% | XXX | XXX | XXX |
EBITDA | $0.7M | $1.7M | XXX | XXX | XXX |
EBITDA Margin | 21% | 33% | XXX | XXX | XXX |
Net Profit | $0.5M | $0.4M | XXX | XXX | XXX |
Net Margin | 14% | 8% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, BPC Instruments's stock price is SEK 35 (or $4).
BPC Instruments has current market cap of SEK 392M (or $40.4M), and EV of SEK 374M (or $38.5M).
See BPC Instruments trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$38.5M | $40.4M | XXX | XXX | XXX | XXX | $0.13 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, BPC Instruments has market cap of $40.4M and EV of $38.5M.
BPC Instruments's trades at 6.0x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate BPC Instruments's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BPC Instruments and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $38.5M | XXX | XXX | XXX |
EV/Revenue | 7.5x | XXX | XXX | XXX |
EV/EBITDA | 22.5x | XXX | XXX | XXX |
P/E | 33.0x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 41.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBPC Instruments's NTM/LTM revenue growth is -100%
BPC Instruments's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged n/a for the same period.
Over next 12 months, BPC Instruments's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BPC Instruments's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BPC Instruments and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 49% | XXX | XXX | XXX | XXX |
EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
EBITDA Growth | 135% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BPC Instruments acquired XXX companies to date.
Last acquisition by BPC Instruments was XXXXXXXX, XXXXX XXXXX XXXXXX . BPC Instruments acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was BPC Instruments founded? | BPC Instruments was founded in 2005. |
Where is BPC Instruments headquartered? | BPC Instruments is headquartered in Sweden. |
How many employees does BPC Instruments have? | As of today, BPC Instruments has 9 employees. |
Is BPC Instruments publicy listed? | Yes, BPC Instruments is a public company listed on SAT. |
What is the stock symbol of BPC Instruments? | BPC Instruments trades under BPCINS ticker. |
When did BPC Instruments go public? | BPC Instruments went public in 2021. |
Who are competitors of BPC Instruments? | Similar companies to BPC Instruments include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
What is the current market cap of BPC Instruments? | BPC Instruments's current market cap is $40.4M |
What is the current revenue of BPC Instruments? | BPC Instruments's last 12-month revenue is $6.4M. |
What is the current EV/Revenue multiple of BPC Instruments? | Current revenue multiple of BPC Instruments is 6.0x. |
What is the current revenue growth of BPC Instruments? | BPC Instruments revenue growth between 2023 and 2024 was 49%. |
Is BPC Instruments profitable? | Yes, BPC Instruments is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.